Kondor Pharma Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Kondor Pharma General Information

Description

Producer of plant-derived health products intended to prevent and treat age-associated diseases. The company's products contain natural ingredients known for their anti-inflammatory properties and cognitive health benefits developed by a team of experienced botanical scientists and medical experts and have undergone clinical testing that reduces neuroinflammation to maintain and restore brain health and slows the progression of cognitive and functional decrease related to aging or neurodegenerative conditions, enabling elderly individuals with neurological disorders to prevent or slow the onset of memory loss.

Contact Information

Website
www.kondorpharma.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 3403 American Drive
  • Misssissauga, Ontario L4V 1T4
  • Canada
+1 (800)
Primary Industry
Other Consumer Non-Durables
Vertical(s)
E-Commerce
Corporate Office
  • 3403 American Drive
  • Misssissauga, Ontario L4V 1T4
  • Canada
+1 (800)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kondor Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 13-Jul-2023 Completed Generating Revenue
1. Accelerator/Incubator 10-Mar-2019 Completed Generating Revenue
To view Kondor Pharma’s complete valuation and funding history, request access »

Kondor Pharma Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Kondor Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3177111-A1 Immunomodulatory and antiviral action of boswellia gum resin extracts, derived formulations, and boswellic acids against respiratory viruses and uses thereof Pending 30-Apr-2020

Kondor Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kondor Pharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
UNM Rainforest Innovations Accelerator/Incubator
Emergence Incubator Accelerator/Incubator Minority
To view Kondor Pharma’s complete investors history, request access »

Ready to get started?

Request a free trial

Kondor Pharma FAQs

  • When was Kondor Pharma founded?

    Kondor Pharma was founded in 2018.

  • Where is Kondor Pharma headquartered?

    Kondor Pharma is headquartered in Misssissauga, Canada.

  • What is the size of Kondor Pharma?

    Kondor Pharma has 6 total employees.

  • What industry is Kondor Pharma in?

    Kondor Pharma’s primary industry is Other Consumer Non-Durables.

  • Is Kondor Pharma a private or public company?

    Kondor Pharma is a Private company.

  • What is Kondor Pharma’s current revenue?

    The current revenue for Kondor Pharma is .

  • Who are Kondor Pharma’s investors?

    UNM Rainforest Innovations and Emergence Incubator have invested in Kondor Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »